Financial and Market Performance - In 2024, the company's operating revenue reached 637 million yuan, representing a year-on-year growth of 25.14% [2] - The net profit attributable to shareholders was 293 million yuan, an increase of 35.06% year-on-year [2] - The net profit after deducting non-recurring gains and losses was 273 million yuan, up 28.62% year-on-year [2] - The net cash flow from operating activities was 316 million yuan, reflecting a growth of 42.61% [2] Core Business Drivers - The company focuses on the research, development, production, and sales of minimally invasive diagnostic and therapeutic instruments, with a wide range of products used in various endoscopic fields [1] - The aging population, increased health awareness, and improved medical insurance levels are driving demand for endoscopic minimally invasive diagnostic and therapeutic instruments, providing significant market opportunities for the company [2] Company Overview - Hangzhou Anjiasi Medical Technology Co., Ltd. was established in December 2010 and successfully went public in May 2023 [1] - The company has applied for a total of 367 patents, with 239 being invention patents, and over 48% of these patents have been applied to products, enhancing its market competitiveness [1][2] Profitability - The gross profit margin for 2024 was 72.11%, an increase of 1.24 percentage points year-on-year [2] - The net profit margin was 46.09%, up 3.38 percentage points compared to the previous year [2] Expense Situation - The company's period expenses for 2024 amounted to 132 million yuan, an increase of 23.48 million yuan year-on-year [2] - The period expense ratio was 20.81%, a decrease of 0.61 percentage points year-on-year [2] - Research and development expenses increased by 43.53% year-on-year, indicating a strong focus on innovation [2] Brand and Customer Resources - The company has established a strong brand image and customer resources through years of market accumulation, forming long-term stable partnerships with numerous medical institutions [2]